Artificial intelligence- and quantum mechanics-based capabilities to Design, Make, Test and Analyse next-generation pharmaceuticals.

A wearable medical device for the continuous monitoring of brain activity and blood flow in stroke patients, providing clinical staff with tremendous value in an otherwise blind situation.

Facilitating the translation of novel scientific discoveries into the next generation of clinical therapeutics, diagnostics and preventatives.

Selected as 1 of 80 applicants across Australia and New Zealand. Focuses on training individuals in the scientific, legal, financial and clinical frameworks required to translate and commercialise new medical technologies.

Facilitating large-scale strategic projects that collectively benefit all our partners: Children's Medical Research Institute, Westmead Institute for Medical Research, Kids Research (Sydney Children's Hospitals Network), University of Sydney, CSIRO, Institute of Clinical Pathology and Medical Research (NSW Health Pathology) and Western Sydney Local Health District.

Cell Signalling Unit. Pharmacological targeting of endocytic proteins for therapeutic benefit. Drug binding site studies. Re-purposing commercially available compounds for novel therapeutic avenues.

Selected as 1 of 100 applicants across Australia and New Zealand. Focuses on training individuals in the scientific, legal, financial and clinical frameworks required to translate and commercialise new medicines in pharmaceutical research.

Demonstrator: Taught first/second year undergraduate university students in anatomy and physiology. Dissectionist: Prepared anatomical samples for university classes.